These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
433 related items for PubMed ID: 12630566
1. The role of caspase cascade on the development of primary Sjögren's syndrome. Hayashi Y, Arakaki R, Ishimaru N. J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566 [Abstract] [Full Text] [Related]
2. Involvement of apoptotic protease cascade for tissue destruction in Sjögren's syndrome. Hayashi Y, Yayagi K, Haneji N. Arch Immunol Ther Exp (Warsz); 2000 Feb; 48(5):399-403. PubMed ID: 11140467 [Abstract] [Full Text] [Related]
3. Prevention and induction of autoimmune exocrinopathy is dependent on pathogenic autoantigen cleavage in murine Sjögren's syndrome. Saegusa K, Ishimaru N, Yanagi K, Mishima K, Arakaki R, Suda T, Saito I, Hayashi Y. J Immunol; 2002 Jul 15; 169(2):1050-7. PubMed ID: 12097413 [Abstract] [Full Text] [Related]
4. Detection of cleaved alpha-fodrin autoantigen in Sjögren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands. Wang Y, Virji AS, Howard P, Sayani Y, Zhang J, Achu P, McArthur C. Arch Oral Biol; 2006 Jul 15; 51(7):558-66. PubMed ID: 16405863 [Abstract] [Full Text] [Related]
5. Development of autoimmune exocrinopathy resembling Sjögren's syndrome in adoptively transferred mice with autoreactive CD4+ T cells. Arakaki R, Ishimaru N, Saito I, Kobayashi M, Yasui N, Sumida T, Hayashi Y. Arthritis Rheum; 2003 Dec 15; 48(12):3603-9. PubMed ID: 14674013 [Abstract] [Full Text] [Related]
6. Apoptosis and Sjögren syndrome. Manganelli P, Fietta P. Semin Arthritis Rheum; 2003 Aug 15; 33(1):49-65. PubMed ID: 12920696 [Abstract] [Full Text] [Related]
7. Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis. Ishimaru N, Yoneda T, Saegusa K, Yanagi K, Haneji N, Moriyama K, Saito I, Hayashi Y. Am J Pathol; 2000 May 15; 156(5):1557-64. PubMed ID: 10793067 [Abstract] [Full Text] [Related]
8. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome. Kobayashi M, Yasui N, Ishimaru N, Arakaki R, Hayashi Y. Arthritis Rheum; 2004 Dec 15; 50(12):3974-84. PubMed ID: 15593201 [Abstract] [Full Text] [Related]
9. Treatment of chronic sialadenitis in a murine model of Sjögren's syndrome by local fasL gene transfer. Fleck M, Zhang HG, Kern ER, Hsu HC, Müller-Ladner U, Mountz JD. Arthritis Rheum; 2001 Apr 15; 44(4):964-73. PubMed ID: 11315936 [Abstract] [Full Text] [Related]
10. Possible involvement of EBV-mediated alpha-fodrin cleavage for organ-specific autoantigen in Sjogren's syndrome. Inoue H, Tsubota K, Ono M, Kizu Y, Mizuno F, Takada K, Yamada K, Yanagi K, Hayashi Y, Saito I. J Immunol; 2001 May 01; 166(9):5801-9. PubMed ID: 11313424 [Abstract] [Full Text] [Related]
11. The role of Fas-Fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice. Jabs DA, Lee B, Whittum-Hudson J, Prendergast RA. Invest Ophthalmol Vis Sci; 2001 Feb 01; 42(2):399-401. PubMed ID: 11157873 [Abstract] [Full Text] [Related]
12. Elevated proapoptotic Bax and caspase 3 activation in the NOD.scid model of Sjögren's syndrome. Masago R, Aiba-Masago S, Talal N, Zuluaga FJ, Al-Hashimi I, Moody M, Lau CA, Peck AB, Brayer J, Humphreys-Beher MG, Dang H. Arthritis Rheum; 2001 Mar 01; 44(3):693-702. PubMed ID: 11263785 [Abstract] [Full Text] [Related]
13. Fas ligand-mediated exocrinopathy resembling Sjögren's syndrome in mice transgenic for IL-10. Saito I, Haruta K, Shimuta M, Inoue H, Sakurai H, Yamada K, Ishimaru N, Higashiyama H, Sumida T, Ishida H, Suda T, Noda T, Hayashi Y, Tsubota K. J Immunol; 1999 Mar 01; 162(5):2488-94. PubMed ID: 10072487 [Abstract] [Full Text] [Related]
14. Transfer of Sjögren's syndrome-like autoimmune lesions into SCID mice and prevention of lesions by anti-CD4 and anti-T cell receptor antibody treatment. Hayashi Y, Haneji N, Hamano H, Yanagi K. Eur J Immunol; 1994 Nov 01; 24(11):2826-31. PubMed ID: 7957574 [Abstract] [Full Text] [Related]
15. Induction of salivary gland epithelial cell injury in Sjogren's syndrome: in vitro assessment of T cell-derived cytokines and Fas protein expression. Abu-Helu RF, Dimitriou ID, Kapsogeorgou EK, Moutsopoulos HM, Manoussakis MN. J Autoimmun; 2001 Sep 01; 17(2):141-53. PubMed ID: 11591123 [Abstract] [Full Text] [Related]
16. Analysis of in vivo role of alpha-fodrin autoantigen in primary Sjogren's syndrome. Miyazaki K, Takeda N, Ishimaru N, Omotehara F, Arakaki R, Hayashi Y. Am J Pathol; 2005 Oct 01; 167(4):1051-9. PubMed ID: 16192640 [Abstract] [Full Text] [Related]
17. Effective treatment of a mouse model of Sjögren's syndrome with eyedrop administration of anti-CD4 monoclonal antibody. Hayashi Y, Ishimaru N, Arakaki R, Tsukumo S, Fukui H, Kishihara K, Shiota H, Yasutomo K, Hayashi Y. Arthritis Rheum; 2004 Sep 01; 50(9):2903-10. PubMed ID: 15457459 [Abstract] [Full Text] [Related]
18. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger? Humphreys-Beher MG, Yamachika S, Yamamoto H, Maeda N, Nakagawa Y, Peck AB, Robinson CP. Eur J Morphol; 1998 Aug 01; 36 Suppl():247-51. PubMed ID: 9825931 [Abstract] [Full Text] [Related]